Search research articles
Contact Us
Filters
Showing results (61-70 of 127) with videos related to
Page
of 13
Sort By:
Molecular Diversity
|
May 28, 2022
High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases
Satyendra Singh, Ketan Kumar, Mamta Panda, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
May 13, 2018
Chemical system biology based molecular interactions to identify inhibitors against Q151M mutant of HIV-1 reverse transcriptase
Rajan Kumar Pandey, Drista Sharma, Rupal Ojha, et al.
International Journal of Biological Macromolecules
|
May 30, 2020
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
Biswajit Naik, Nidhi Gupta, Rupal Ojha, et al.
Journal of Biomolecular Structure & Dynamics
|
August 26, 2015
Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach
Rajan Kumar Pandey, Drista Sharma, Tarun Kumar Bhatt, et al.
Life Sciences
|
July 5, 2022
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
February 3, 2021
Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges
Arun Upadhyay, Naveen Sundaria, Rohan Dhiman, et al.
Advances in Protein Chemistry and Structural Biology
|
February 20, 2025
From past to present: The evolution of immunotherapy and its modern modalities
Surbhi Dadwal, Sarthak Dhar, Kirti Baghel, et al.
Journal of Receptor and Signal Transduction Research
|
May 6, 2016
Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase
Rajan Kumar Pandey, Bajarang Vasant Kumbhar, Shyam Sundar, et al.
Experimental Parasitology
|
October 2, 2012
A rapid method to assess the stage differentiation in Leishmania donovani by flow cytometry
Alti Dayakar, Sambamurthy Chandrasekaran, Vijay Kumar Prajapati, et al.
Journal of Clinical Microbiology
|
March 26, 2010
Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis
Radheshyam Maurya, Sanjana Mehrotra, Vijay Kumar Prajapati, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 127) with videos related to
Sort By:
Page
of 13
Molecular Diversity
|
May 28, 2022
High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases
Satyendra Singh, Ketan Kumar, Mamta Panda, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
May 13, 2018
Chemical system biology based molecular interactions to identify inhibitors against Q151M mutant of HIV-1 reverse transcriptase
Rajan Kumar Pandey, Drista Sharma, Rupal Ojha, et al.
International Journal of Biological Macromolecules
|
May 30, 2020
High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment
Biswajit Naik, Nidhi Gupta, Rupal Ojha, et al.
Journal of Biomolecular Structure & Dynamics
|
August 26, 2015
Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach
Rajan Kumar Pandey, Drista Sharma, Tarun Kumar Bhatt, et al.
Life Sciences
|
July 5, 2022
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
February 3, 2021
Complex Inclusion Bodies and Defective Proteome Hubs in Neurodegenerative Disease: New Clues, New Challenges
Arun Upadhyay, Naveen Sundaria, Rohan Dhiman, et al.
Advances in Protein Chemistry and Structural Biology
|
February 20, 2025
From past to present: The evolution of immunotherapy and its modern modalities
Surbhi Dadwal, Sarthak Dhar, Kirti Baghel, et al.
Journal of Receptor and Signal Transduction Research
|
May 6, 2016
Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase
Rajan Kumar Pandey, Bajarang Vasant Kumbhar, Shyam Sundar, et al.
Experimental Parasitology
|
October 2, 2012
A rapid method to assess the stage differentiation in Leishmania donovani by flow cytometry
Alti Dayakar, Sambamurthy Chandrasekaran, Vijay Kumar Prajapati, et al.
Journal of Clinical Microbiology
|
March 26, 2010
Evaluation of blood agar microtiter plates for culturing leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis
Radheshyam Maurya, Sanjana Mehrotra, Vijay Kumar Prajapati, et al.
Page
of 13